Clinical impact of absolute SPECT/CT quantification in theranostics and dosimetry

By Partha Ghosh, MD, Siemens Healthineers, Hoffman Estates, Illinois, USA

|17/2/23
Integration of SPECT/CT imaging and radionuclide therapy for an ever-increasing spectrum of cancers points to a promising future for such therapies. Explore this white paper and discover how accurate quantification of tracer concentration with SPECT/CT is potentially key to dosimetry and optimal therapy outcomes.